<DOC>
	<DOCNO>NCT01251211</DOCNO>
	<brief_summary>Pain due peripheral nerve lesion remain extremely difficult treat current treatment onl moderate efficacy and/or side effect . The investigator previously demonstrate long term efficacy Botulinum toxin type A ( BTX-A ) small group patient post-traumatic/postherpetic neuralgia allodynia . The present study aim a/ confirm efficacy repeat application BTX-A large group patient peripheral neuropathic pain without allodynia ( primary outcome ) ; b/ evaluate mechanism action ; c/analyse predictor response ; d/analyse whether second injection associate therapeutic gain . This randomized placebo control study . A total 30 patient randomize receive either BTX-A ( subcutaneous injection painful area ) placebo . Each injection repeat within least 3 month depend duration efficacy . Skin punch biopsy perform 1 month BTX-A administration . The investigator postulate study confirm clinical efficacy good safety repeat administration BTX-A treatment peripheral neuropathic pain .</brief_summary>
	<brief_title>Botulinum Toxin Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men woman age 18 85 year Spontaneous pain minimal intensity 4/10 numerical scle Pain present least 6 month Pain relate painful mononeuropathy sensory polyneuropathy Able understand protocol comply requirement study Written inform consent Painful area limit maximum 240 cm2 Facial pain Litigation ( pending ) Unstable condition responsible neuropathic pain ( ie , unstable immunological disease ... ) HIV chemotherapy induce neuropathy Contraindications BTXA ( neuromuscular disease , hypersensitivity , infection , coagulation disorder , pregnancy ) Other pain severe neuropathic pain No compliance self diary Drug abuse alcoholism Severe major depression Cognitive impairment Other research protocol within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>BOTULINUM TOXIN</keyword>
	<keyword>NEUROPATHIC PAIN</keyword>
	<keyword>RANDOMIZED CONTROLLED TRIAL</keyword>
</DOC>